For expats living in Bangkok, understanding the difference between these treatments is importantnot just from a results perspective, but also in terms of how they work, how they are prescribed, and what may be suitable for your individual health profile
Compounding pharmacies prepare medications for individual patients based on individual prescriptions without the same premarket FDA review that finished drug products go through
Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement
Semaglutide provides a steady, long-term approach with added metabolic benefits
E ngage in light physical activity, like walking, after meals